Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South Africa.
Cheingsong-Popov
R
R
Williamson
C
C
Lister
S
S
Morris
L
L
van Harmelen
J
J
Bredell
H
H
Wood
R
R
Sonnenberg
P
P
van der Ryst
E
E
Martin
D
D
Weber
J
J
D004196:Disease Outbreaks; D005260:Female; D015483:HIV Antibodies / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000145:classification / Q000276:immunology*; D015658:HIV Infections / Q000453:epidemiology / Q000821:virology*; D015497:HIV-1 / Q000145:classification* / Q000235:genetics; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000145:classification / Q000276:immunology*; D012680:Sensitivity and Specificity; D012703:Serotyping; D013019:South Africa / Q000453:epidemiology
D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments